Scraping Fibrosis: Expressway to the Core of Fibrosis

Overview

Journal Nat Med

Specialties General Medicine
Molecular Biology

Date 2011 May 7

PMID 21546973

Citations 102

Authors

Wajahat Z Mehal

John Iredale

Scott L Friedman

Affiliations

Soon will be listed here.

Citing Articles

Physical Exercise: A Promising Treatment Against Organ Fibrosis.

Ma X, Liu B, Jiang Z, Rao Z, Zheng L Int J Mol Sci. 2025; 26(1.

PMID: 39796197 PMC: 11720236. DOI: 10.3390/ijms26010343.

Live-cell imaging of human liver fibrosis using hepatic micro-organoids.

Guan Y, Fang Z, Hu A, Roberts S, Wang M, Ren W JCI Insight. 2024; 10(2).

PMID: 39656528 PMC: 11790020. DOI: 10.1172/jci.insight.187099.

The role of IL-17 family cytokines in cardiac fibrosis.

Huang L Front Cardiovasc Med. 2024; 11:1470362.

PMID: 39502194 PMC: 11534612. DOI: 10.3389/fcvm.2024.1470362.

SGLT-2 inhibitors as novel treatments of multiple organ fibrosis.

Hu J, Teng J, Hui S, Liang L Heliyon. 2024; 10(8):e29486.

PMID: 38644817 PMC: 11031788. DOI: 10.1016/j.heliyon.2024.e29486.

Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis.

Min K, Yenilmez B, Kelly M, Echeverria D, Elleby M, Lifshitz L Elife. 2024; 12.

PMID: 38564479 PMC: 10987092. DOI: 10.7554/eLife.89136.

References

Barry-Hamilton V, Spangler R, Marshall D, McCauley S, Rodriguez H, Oyasu M . Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med. 2010; 16(9):1009-17. DOI: 10.1038/nm.2208. View

Nelson D, Tu Z, Soldevila-Pico C, Abdelmalek M, Zhu H, Xu Y . Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology. 2003; 38(4):859-68. DOI: 10.1053/jhep.2003.50427. View

Russo F, Alison M, Bigger B, Amofah E, Florou A, Amin F . The bone marrow functionally contributes to liver fibrosis. Gastroenterology. 2006; 130(6):1807-21. DOI: 10.1053/j.gastro.2006.01.036. View

Wynn T . Cellular and molecular mechanisms of fibrosis. J Pathol. 2007; 214(2):199-210. PMC: 2693329. DOI: 10.1002/path.2277. View

Berres M, Koenen R, Rueland A, Zaldivar M, Heinrichs D, Sahin H . Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J Clin Invest. 2010; 120(11):4129-40. PMC: 2964968. DOI: 10.1172/JCI41732. View

Rosenbloom J, Castro S, Jimenez S . Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies. Ann Intern Med. 2010; 152(3):159-66. DOI: 10.7326/0003-4819-152-3-201002020-00007. View

Morishima C, Paschal D, Wang C, Yoshihara C, Wood B, Yeo A . Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology. 2006; 43(3):573-80. DOI: 10.1002/hep.21073. View

McHutchison J, Goodman Z, Patel K, Makhlouf H, Rodriguez-Torres M, Shiffman M . Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection. Gastroenterology. 2009; 138(4):1365-73, 1373.e1-2. DOI: 10.1053/j.gastro.2009.12.003. View

Di Bisceglie A, Shiffman M, Everson G, Lindsay K, Everhart J, Wright E . Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med. 2008; 359(23):2429-41. PMC: 2606037. DOI: 10.1056/NEJMoa0707615. View

10.

Radaeva S, Sun R, Jaruga B, Nguyen V, Tian Z, Gao B . Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology. 2006; 130(2):435-52. DOI: 10.1053/j.gastro.2005.10.055. View

11.

Pockros P, Jeffers L, Afdhal N, Goodman Z, Nelson D, Gish R . Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis. Hepatology. 2007; 45(3):569-78. DOI: 10.1002/hep.21561. View

12.

Melhem A, Muhanna N, Bishara A, Alvarez C, Ilan Y, Bishara T . Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol. 2006; 45(1):60-71. DOI: 10.1016/j.jhep.2005.12.025. View